Share

FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture

The U.S. Food and Drug Administration has approved romosozumab-aqqg to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are women with a history of osteoporotic fracture or multiple risk factors for fracture, or those who have failed or are intolerant to other osteoporosis therapies. The drug will be marketed...
Share

Genetic Studies Provide Possible Mechanistic Link Between Endometriosis and Ovarian Cancer

Genetic breakthroughs from three recent whole-exome sequencing studies of endometrial and endometriotic epithelial cells provided some unexpected findings linking endometriosis and ovarian cancer, according to a paper recently published in Endocrinology. The paper, by Serdar E. Bulun, MD, of the Feinberg School of Medicine at Northwestern University in Chicago, notes that while associations between endometriosis...
Share

Endocrine Society Objects to Title X Gag Rule That Limits Women’s Access to Contraception

Denying preventive services increases medical costs, jeopardizes public health The Endocrine Society objects to the administration’s decision to severely restrict access to the Title X Family Planning Program, the nation’s only program for affordable birth control and reproductive care. The Title X program is essential in helping ensure that every person — regardless of income,...
Share

Prenatal Precautions: Thyroid Function in Pregnancy

Thyroid dysfunction is fairly common among pregnant women and can often result in additional obstetric complications. A new study published in The Journal of Clinical Endocrinology & Metabolism shows that thyroid screening — despite some controversy as to its usefulness — could help identify women who might benefit from additional prenatal care. Pregnancy places quite a...